VAB Examines NFL 2023 Season's Record-Breaking Viewership Growth
—The Taylor Swift Effect, Increased Female Viewership, Primetime Spanish Broadcasts Among Key Factors Cited In New Report—
"2023 was a terrific audience growth year for NFL Football, with growth spikes across all important measures and across both streaming and linear platforms. Engagement metrics also spiked during these live and communal games, so many match-ups were 'big events'," said
Among the key factors of audience growth for 2023 NFL primetime games:
- The 'Swifties Effect' is real and the hype around
Taylor Swift attending Chiefs games drew female audiences to the live NFL broadcasts. - Increased female viewership extended beyond Chiefs games with the audience growing by nearly
one-third across the NFL season. - NFL primetime games on Spanish-language networks creates a cultural connection across both linear TV and streaming.
- NFL viewership saw double-digit growth across linear TV and streaming as more viewers tuned in to watch from inside, and outside, their home.
- Modern measurement solutions show viewership lifts against panel only data on average, especially among Spanish-language networks.
Read the full report—which includes additional data, insights and analysis—here.
ABOUT VAB
The Video Advertising Bureau (VAB)—whose members include the national TV networks alongside a broader community of influential media companies—plays a dual role in the video advertising industry. VAB is fiercely advocating for the changes that bring about a more innovative and transparent marketplace. VAB also provides the insights and thought leadership that enables marketers to develop business-driving marketing strategies. Visit VAB online and access its continuously growing content library at thevab.com.
Media Contact: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/vab-examines-nfl-2023-seasons-record-breaking-viewership-growth-302055345.html
SOURCE VAB
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
- A New Yangtze Icon: Vista Cruises Unveils Vista Aurora
- Jura Announces Maru-3 Completion and Test Results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share